肺癌患者的财务毒性：范围综述方案。
Financial toxicity in patients with lung cancer: a scoping review protocol.
机构信息
Department of Nursing, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China.
出版信息
BMJ Open. 2022 May 24;12(5):e057801. doi: 10.1136/bmjopen-2021-057801.
INTRODUCTION
Lung cancer has the second-ranked morbidity rate and the first-ranked mortality rate worldwide. With the progression of the cancer condition and the advancement of new treatments, the corresponding medical expenses have risen sharply. Nowadays, financial toxicity has become one of the most common concerns in patients with cancer. However, by far, the full landscape of studies on financial toxicity is unclear in patients with lung cancer. Thus, this scoping review aims to summarise the degree, affecting factors, outcomes and intervention strategies of financial toxicity in patients with lung cancer.
METHODS AND ANALYSIS
This scoping review will be developed following the methodology described in the Joanna Briggs Institute Manual for Evidence Synthesis on scoping review protocol, which was based on Arksey and O'Malley's methodological framework, Levac 's recommendations for applying this framework and Peters 's enhancements of the framework. From the day of database building to 31 December 2021, 10 English databases will be searched in the 'Abstract' field with three key search terms: "Lung", "Cancer" and "Financial toxicity". The studies' screening and data extraction will be independently performed by two reviewers (MZ and RZ). Any disagreements between the two reviewers (MZ and RZ) will be resolved by consensus, and a third reviewer (BW) will be invited if necessary. The results will be analysed and presented using tables and figures. This scoping review will be reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist.
ETHICS AND DISSEMINATION
An ethical approval is not required for this scoping review protocol, nor for the scoping review. The results of this scoping review will be disseminated through publication in a peer-reviewed journal or presentation at conferences.
REGISTRATION
This scoping review protocol has been registered in the Open Science Framework (https://osf.io/ub45n/?view_only=bb93eb94e1434a0f8196b3b61cffcec2).
简介
肺癌是全球发病率排名第二、死亡率排名第一的癌症。随着癌症病情的发展和新治疗方法的出现，相应的医疗费用急剧上升。如今，经济毒性已成为癌症患者最常见的关注点之一。然而，迄今为止，肺癌患者经济毒性的研究全貌尚不清楚。因此，本范围综述旨在总结肺癌患者经济毒性的程度、影响因素、结果和干预策略。
方法和分析
本范围综述将根据乔安娜·布里格斯研究所（Joanna Briggs Institute）关于范围综述方案的证据综合手册中描述的方法进行制定，该手册基于阿斯基和奥马利（Arksey and O'Malley）的方法框架、莱瓦克（Levac）对该框架的应用建议以及彼得斯（Peters）对该框架的改进。从数据库建立之日起至 2021 年 12 月 31 日，将在 10 个英文数据库的“摘要”字段中使用三个关键搜索词搜索“肺”、“癌”和“经济毒性”。两位评审员（MZ 和 RZ）将独立进行研究筛选和数据提取。如果两位评审员（MZ 和 RZ）之间存在分歧，将通过协商解决，如果需要，将邀请第三位评审员（BW）。结果将使用表格和图形进行分析和呈现。本范围综述将按照系统评价和荟萃分析扩展的首选报告项目清单进行报告。
伦理和传播
本范围综述方案和范围综述均无需伦理批准。本范围综述的结果将通过在同行评议期刊上发表或在会议上展示来传播。
注册
本范围综述方案已在开放科学框架（https://osf.io/ub45n/?view_only=bb93eb94e1434a0f8196b3b61cffcec2）上注册。
Zotero 插件